Heightened interest in tricuspid regurgitation (TR) stems from the consistent association of
mortality with greater severity of TR, and a low use of surgical solutions in the setting of high …

Assessing the severity of tricuspid regurgitation remains a challenging task, and although
echocardiography is the test of choice, significant limitations of the current recommendations …

Background Tricuspid regurgitation (TR) is a frequent disease with a progressive increase in
mortality as disease severity increases. Transcatheter therapies for treatment of TR may offer …

Background Tricuspid regurgitation is a prevalent disease associated with high morbidity
and mortality, with few treatment options. The aim of the TRILUMINATE trial is to evaluate …

Valvular disease remains a major cause of cardiovascular morbidity and mortality
worldwide. 1 Over the past decade, catheter-based interventions in valvular disease have …

The adverse effects of severe tricuspid regurgitation (TR) on longterm outcomes has now
been reported in a number of natural history studies. 1, 2 Current treatment for TR is …

Objectives: A large, prospective international registry was developed to evaluate the initial
clinical applications of transcatheter tricuspid valve intervention (TTVI) with different devices …

Tricuspid regurgitation is a common finding in patients with left-sided valvular or myocardial
disease, often being a marker for late-stage chronic heart failure with a grim prognosis …

Tricuspid regurgitation (TR) is classified according to different morphologic types based on
the underlying mechanisms: primary, secondary, and isolated TR. Primary TR is caused by …

Background: Severe tricuspid regurgitation (TR) is associated with high morbidity and
mortality rates with limited treatment options. Objectives: The authors report the 6-month …